The Evaluation of Plasmin and Streptokinase Activator Complexes in a New Rabbit Model of Venous Thrombosis

Summary

A new quantitative model for the examination of potential thrombolytic agents is described. A thrombus was formed in the inferior vena cava of the rabbit, using ¹²⁵I-labelled fibrinogen mixed with a standard amount of thromboplastin. The thrombus was anchored securely by means of a woollen thread inserted longitudinally into the lumen of the vein. Thrombotic extension of the radioactive clot and rethrombosis during the experimental period (5 h) were prevented by the administration of intravenous heparin. In control animals, the thrombus remained stable and there was no rise in the radioactivity of the circulating blood during 5 h. In animals given thrombolytic agents, lysis could be followed continuously by measuring the rise in blood radioactivity. Total lysis was determined by counting the radio-label in the residual clot after treatment.

The model has been used to study the thrombolytic activity of streptokinase-human plasminogen complexes, activator-free plasmins of human and porcine origin, and human plasmin produced by streptokinase (SK) activation of human plasminogen. The role of activator complexes in the thrombolytic activity of SK-activated plasmin is discussed.

Keywords

Thrombolysis - Streptokinase-plasminogen complex - Plasmin - Rabbit

• References

• 1 Smith RA G, Dupe RJ, English PD, Green J. Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy. Nature (London) 1981; 290: 505-508
• 2 Henry RL. In: Thrombosis and bleeding disorders. 1971. Academic Press; London: p 498
• 3 Klöcking HP. In: Fibrinolytics and antifibrinolytics. Ed. Markwardt F. Springer-Verlag; Berlin: 1978. p 151
• 4 Johnson AJ, Tillet WS. The lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system (streptokinase). J Exp Med 1952; 95: 449-463
• 5 Ambrus JL, Ambrus CM, Back N, Sokal JE, Collins GL. Clinical and experimental studies on fibrinolytic enzymes. Ann N Y Acad Sci 1957; 68 (01) 97-135
• 6 Hirsh J, Buchanan M, Glynn MF, Mustard JF. Effect of activation of the fibrinolytic mechanisms on experimental platelet-rich thrombi in rabbits. J Lab Clin Med 1968; 72: 245-255
• 7 Nowak A, Gurewich V. Thrombolysis with streptokinase in rabbits, dose-response, fibrin-clot specificity and laboratory evaluation of fibrinolytic effect. Thrombos Diathes haemorrh 1974; 31: 265-272
• 8 Markwardt F, Klöcking H-P, Sedlarck K, Perlewitz J, Draivert J, Hoffman J. Tierexperimentelle Untersuchungen zur thrombolytischen Wirkung von Streptokinase. Acta Biol Med Germ 1976; 35: 193-201
• 9 Jorgensen L, Hirsh J, Glynn MF, Buchanan MR, Mustard JS. Effect of streptokinase therapy on experimental fibrin-rich arterial thrombi. Am J Path 1971; 62: 7-18
• 10 Roschlau WH E. The evaluation in the dog of a proteolytic enzyme derived from Aspergillus oryzae. Can J Physiol Pharmacol 1964; 42: 109
• 11 Burmester HB C, Aulton K, Horsfield GI. Evaluation of a rapid method for the determination of plasma fibrinogen. J Clin Pathol 1970; 23: 43-46
• 12 Deutsch DE, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096
• 13 Weber K, Pringle JR, Osborn M. In. Methods in Enzymology. Hirs CH W, Timasheff SN. Ed Academic Press; New York/London: 1972. 26C 5-27
• 14 Erlanger BF, Kokowsky N, Cohen W. The preparation and properties of two new chromogenic substrates of trypsin. Arch Biochem Biophys 1961; 95: 271-278
• 15 Smith RA G, Green J, Kopper PH. The purification and properties of a fibrinolytic neutral metallendopeptidase from Streptococcus faecalis. Arch Biochem Biophys 1980; 202: 629-638
• 16 Chase T, Shaw E. p-Nitrophenyl p’-guanidinobenzoate HCl. A new active site titrant for trypsin Biochem Biophys Res Commun 1967; 29: 508-514
• 17 McClintock DK, Bell PH. The mechanism of activation of human plasminogen by strepokinase. Biochem Biophys Res Commun 1971; 43: 694-702
• 18 Sherry S. Fibrinolysis. Ann Revs Med 1968; 13: 247-268
• 19 Deutsch E. Endogenous and exogenous thrombolysis. Thrombos Diathes haemorrh Suppl (Suppl. 47) 1971; 145-151
• 20 Robbins KC, Summaria L, Friedman L, Rabiner SF. Fibrinolytic activity of an isolated equimolar human plasmin-streptokinase activator complex in an experimental dog model. Microv Res 1974; 6: 114-119
• 21 Markus G, Evers JL, Hobika GH. Activator activities of the transient forms of the human plasminogen-streptokinase complex during its proteolytic conversion to the stable activator complex. J Biol Chem 1976; 251: 6495-6504
• 22 Jester H-G. Aktivatortherapie akuter Venenthrombosen. Dtsch. Med Wschr 1978; 103: 1922-1925
• 23 Sherry S, Fletcher AP. Proteolytic enzymes: a therapeutic evaluation. Clin Pharmacol Ther 1960; 1: 202-226
• 24 Alkjaersig N, Fletcher AP, Sherry S. The mechanisms of clot dissolution by plasmin. J Clin Invest 1959; 38: 1086-1095
• 25 Sherry S, Fletcher AP, Alkjaersig N. Fibrinolysis and fibrinolytic activity in man. Physiol Rev 1959; 39: 343-382
• 26 Collen D. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. Eur J Biochem 1976; 69: 209-216
• 27 Müllertz S, Clemmensen I. The primary inhibitor of plasmin in human plasma. Biochem J 1976; 159: 545-553
• 28 Summaria L, Arzadon L, Bernabe P, Robbins KC. The interaction of streptokinase with human, cat, dog and rabbit plasminogen. J Biol Chem 1974; 249: 4760-4769
• 29 Ling C-M, Summaria L, Robbins KC. Isolation and characterization of bovine plasminogen activator from a human plasminogen-strepto-kinase mixture. J Biol Chem 1967; 242: 1419-1425